Sigma Healthcare stock
Price history
−1.02% over the period1 year: from $2.93 (November 17, 2025) to $2.90 (November 16, 2026), −1.02%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | $2.90 |
| October 30, 2026 | $2.73 |
| September 30, 2026 | $2.59 |
| August 31, 2026 | $2.69 |
| July 31, 2026 | $2.94 |
| June 30, 2026 | $2.75 |
| May 29, 2026 | $2.94 |
| April 30, 2026 | $2.79 |
| March 31, 2026 | $2.65 |
| February 27, 2026 | $2.84 |
| January 30, 2026 | $3.09 |
| December 31, 2025 | $2.94 |
| November 28, 2025 | $2.88 |
| November 17, 2025 | $2.93 |
At a glance
The company
Retail pharmacy franchisor and pharmaceutical wholesale distributor serving community pharmacies across Australia and internationally
Latest results
Quarter to June 30, 2026 · EPS $0.03
TickerLandia's take on Sigma Healthcare
- Pricier than similar companies: trailing 12-month P/E 48 vs 28 (+71%) in a group of 11.
- Strong point: Growth (86/100 in its group). Weak point: Earnings stability (30/100).
- “Beat the market” (Australia): No. 7 of 193.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−9.38% from the 52-week high
Analysts · 16 analysts
Average target$3.15+8.75% vs. price
Buy 11 · Hold 5 · Sell 0 · Buy
TickerLandia Fingerprint: Sigma Healthcare
Compared with similar companies: very high price, very high growth, and very high profitability.
Financials and price compared with 11 companies in the medical distribution industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricevery high93
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 48.2 95 Forward P/E 33.0 95 EV/EBITDA 33.8 95 Price/book 6.66 83 Price/sales 3.08 95 Profitabilityvery high84
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 9.2% 86 Gross margin 18.1% 68 Net margin 6.5% 95 ROE 14.7% 75 ROA 7.2% 95 Earnings stabilitylow30
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.9% 5 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 55 Growthvery high86
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) +44.00% 68 Revenue growth (year over year) +31.90% 95 Average revenue growth (3 years) +51.91% 95 Financial strengthhigh72
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 0.40 85 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.82 50 Current ratio 1.67 95 Interest coverage 8.69 59 Dividendaverage52
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 66.7% 75 Consecutive dividend years 6 years 27 Dividend yield 1.4% 55 Market momentumaverage46
How the stock has moved compared with the market.
Metric Value Position in group Distance from 200-day average +3.14% 64 1-year return −5.86% 36 Relative strength (3 months) −1.89% 41 Relative strength (6 months) −3.98% 43 Risklow25
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 20.9% 18 Volatility (60 days) 25.0% 19 Beta (1 year) 0.55 36
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Sigma Healthcare is pricier than similar companies
Sigma Healthcare's P/E (trailing 12 months): 48.2, +71% against the median of a group of 11 similar companies (28.2).
Compared with 11 similar companies
| Metric | Sigma Healthcare | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 48.2 | High | |
| Forward P/E | 33.0 | High | |
| Operating margin | 9.2% | High | |
| ROE | 14.7% | High | |
| Debt/equity | 0.40 | Low |
Grey band: the middle half of the group; tick: the median; dot: Sigma Healthcare. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$5.33B
Latest quarter · Q2 2026
Net income
$329.36M
Latest quarter · Q2 2026
Quarterly net margin
6.2%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $33.36B
- P/E
- 48.2
- EPS
- $0.06
- Volume
- 15.33M
- Daily trading
- €42.86M
- Dividend yield
- 1.38%
- Last ex-dividend on September 3, 2026
How Sigma Healthcare is changing
All resultsRevenue grew 35.0% a year on average over the last 5 years
Operating margin fell from 13.9% to 9.2%
Free cash flow equal to 73% of net income
Returns
Sigma Healthcare returns with dividends
$1,000 invested in Sigma Healthcare 5 years ago, on November 16, 2021, would be worth $6,339 today with dividends reinvested: +533.94% in total, +44.69% per year. On price alone it would be $5,919 (+491.90%).
| Period | Sigma Healthcare | S&P/ASX 200 | $1,000 becomes |
|---|---|---|---|
| 1 month | +1.75% | +3.40% | $1,018 |
| 6 months | +1.40% | +5.23% | $1,014 |
| Year to date | −1.36% | +4.22% | $986 |
| 1 year | +0.43% | +5.16% | $1,004 |
| 3 years | +325.88% | +28.67% | $4,259 |
| 5 years | +533.94% | +22.40% | $6,339 |
| 10 years | +198.77% | +70.47% | $2,988 |
Over the last 6 months it has done better than 18% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment
The chart in detail
Sigma Healthcare: technical analysis
Sigma Healthcare shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 76.0% below its all-time closing high ($12.07, October 28, 2004).
- Trend
- No clear trend
- RSI (14 sessions)
- 70
- Between 30 and 70
- vs 200-session average
- +3.55%
Support and resistance
Price areas where Sigma Healthcare has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$3.20+10.17%2 touches, last on February 26, 2026
- Resistance$3.00+3.28%3 touches, last on August 14, 2026
- Resistance$2.96+1.98%4 touches, last on July 20, 2026
- Last price$2.90
- Support$2.87−1.03%2 touches, last on October 19, 2026
- Support$2.81−3.08%9 touches, last on July 24, 2026
- Support$2.75−5.30%4 touches, last on April 29, 2026
Volatility and risk
Over the last year it has moved less than the S&P/ASX 200.
- Beta (1 year) vs S&P/ASX 200
- 0.52
- Volatility (60 sessions, annualised)
- 25.0%
- Largest fall in the last year
- −20.89%
Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Sigma Healthcare: seasonality
Average monthly price change over 27 years
Over the last 27 years, the strongest month for Sigma Healthcare has been November: +3.48% on average, positive in 16 years out of 26. The weakest has been April: −2.77% on average, positive in 9 years out of 27.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.54% | +2.15% | 14 of 26 |
| February | +1.32% | +0.76% | 14 of 27 |
| March | +0.81% | +2.26% | 15 of 27 |
| April | −2.77% | −1.25% | 9 of 27 |
| May | −0.20% | +0.25% | 14 of 27 |
| June | +2.68% | 0.00% | 13 of 27 |
| July | +1.06% | +5.08% | 17 of 27 |
| August | +2.93% | +2.78% | 18 of 27 |
| September | −0.92% | −3.88% | 8 of 27 |
| October | +1.89% | −1.72% | 12 of 27 |
| November | +3.48% | +2.24% | 16 of 26 |
| December | +1.65% | +1.38% | 14 of 26 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Sigma Healthcare and its competitors
Founded in 1912 and headquartered in Preston, Australia, Sigma Healthcare Limited works as a franchisor of retail pharmacies and as a wholesaler supplying community pharmacies in Australia and abroad. Its franchised network trades under the Chemist Warehouse, Amcal, Discount Drug and PriceSave names, and the group also distributes medicines, medical supplies, healthcare and beauty goods to these outlets and to other third parties. Beyond stock supply, it sells advertising and marketing services and support services for pharmacies, and offers MPS Connect, a medication management solution. Products are also sold online.
- Headquarters
- Preston, Australia
- Founded
- 1912
- Chief executive
- Vikesh Ramsunder
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Sigma HealthcareSIG | $22.64B | 9.2% | 48.2 | +1.40% |
| Sinopharm Group Ltd H1099 | $6.63B | 3.0% | 6.59 | −5.15% |
| Henry ScheinHSIC | $9.74B | 5.8% | 24.2 | +24.15% |
| Cardinal HealthCAH | $64.97B | 1.3% | 36.4 | +50.85% |
| CencoraCOR | $68.51B | 1.4% | 20.0 | +40.42% |
| GalenicaGALE | $5.42B | 4.8% | 28.2 | +11.17% |
Same industry or related industries, similar size. Compare Sigma Healthcare with its competitors · Full profile
